Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12612000864820
ACTRN12612000864820
Not yet recruiting
Phase 2

A short term study of safety and glycaemic outcomes in peritoneal dialysis patients with type 2 diabetes treated with metformin

Tilenka Thynne0 sites6 target enrollmentAugust 15, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 2 DiabetesChronic kidney Disease- on peritoneal dialysisMetabolic and Endocrine - DiabetesRenal and Urogenital - Kidney disease

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Tilenka Thynne
Enrollment
6
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 15, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tilenka Thynne

Eligibility Criteria

Inclusion Criteria

  • •(1\)\>18 years old
  • •(2\)Type 2 DM
  • •(3\)Peritoneal Dialysis treatment of chronic kidney disease
  • •(4\)Patients in whom metformin would be used if they had normal renal function

Exclusion Criteria

  • •(1\)Any patient in whom metofrmin would not be used in the setting of normal renal function\- moderate\-severe heart failure, liver failure, alcohol abuse, major psychaitric disorder, acutely unwell or otherwise medically unstable.
  • •(2\)Unability or unwilling to measure own blood glucose concentrations via glucometer.
  • •(3\)Inability to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysis
ACTRN12612000352808Dr Tilenka Thynne6
Completed
Not Applicable
Assessment of safety and glycaemia during application of the hybrid closed-loop system on the basis of the AndroidAPS application.E10Type 1 diabetes mellitus
DRKS00015439Diabetes Poland12
Recruiting
Not Applicable
Observational study of efficacy of glucose level in saliva as a marker of blood sugar in perioperative or diabetic patients1.diabetes mellitus 2.intracranial vessel disease
JPRN-UMIN000010920Fukuoka University Department of Anesthesiology40
Completed
Not Applicable
Evaluation of the effects on blood glucose level: a randomized, double-blind, crossover trialHealthy Japanese adult people
JPRN-UMIN000030701ORTHOMEDICO Inc.10
Completed
Not Applicable
Correlation of long-term glycaemic control with blood Angiopoietin-like protein levels in diabetes patients
CTRI/2018/05/014272ady Hardinge Medical College65